BioRestorative Therapies Expands Stem Cell Research with New York State License
In a significant advancement for regenerative medicine, BioRestorative Therapies, Inc. has secured a provisional license from the New York State Department of Health (NYSDOH) to process allogeneic (non-autologous) donor tissue material, including stem cells, for medical research. This expansion builds upon their previous authorization, which was limited to autologous (self-donated) mesenchymal stem cells. This new […]
Unlocking the Power of Stem Cells: Dr. Adeel Khan’s Comprehensive Guide
In the realm of regenerative medicine, stem cells represent a groundbreaking frontier that could redefine how we treat chronic pain, autoimmune conditions, and even the process of aging. In Dr. Adeel Khan’s insightful talk, he delves deep into the science of stem cells and peptides, exploring the transformative potential of these cells and the challenges […]
Pioneering Stem Cell Therapy Shows Promise in Alzheimer’s Treatment: Regeneration Biomedical Releases First Cohort Results
In a breakthrough for Alzheimer’s disease research, Regeneration Biomedical, Inc. recently presented promising findings from a Phase I clinical trial that delivers stem cell therapy directly into the brains of patients. Utilizing Wnt-activated, autologous, expanded, adipose-derived stem cells (RB-ADSCs), the therapy is designed to potentially slow or reverse the progression of Alzheimer’s. These specialized stem […]
BioCardia Completes Phase III Clinical Trial of Autologous Stem Cell Therapy for Ischemic Heart Failure
BioCardia, Inc., a leader in cellular therapies for cardiovascular diseases, has announced the completion of its pivotal Phase III trial for CardiAMP®, an autologous cell therapy designed to treat ischemic heart failure with reduced ejection fraction (HFrEF). This milestone marks the last patient follow-up in the double-blind, placebo-controlled trial, which aims to assess the safety […]
Unlocking the Future of Medicine: The Transformative Power of Stem Cells with Dr. Urban Kiernan & Dr. Neil Morris
In this fascinating episode of the Decoding Health Podcast, experts Dr. Urban Kiernan and Dr. Neil Morris dive deep into the rapidly evolving world of stem cell research. They discuss how stem cells are revolutionizing modern medicine, from their potential in regenerative therapies to cutting-edge applications in treating chronic diseases. Learn how these pioneering advancements […]
Binaural Beats for Stem Cell Regeneration: Real Benefits or Just Hype?
Let’s be real. You’re here because you’ve heard whispers about binaural beats potentially kick-starting stem cell regeneration. But you’re probably wondering: does it really work, or is it just another trend getting people excited for nothing? We get it. The promise of listening to some sounds and seeing health benefits sounds almost too good to […]
Factor Bioscience and Eterna Therapeutics Partner to Accelerate Advanced Cell Therapies for Cancer, Rare Diseases, and Autoimmune Disorders
In a groundbreaking collaboration that promises to reshape the future of medicine, Factor Bioscience and Eterna Therapeutics have announced an exclusive license agreement to accelerate the development of stem cell-based therapies for oncology, autoimmune disorders, and rare diseases. The agreement is centered around the utilization of Factor’s proprietary induced pluripotent stem cell (iPSC) technologies, which […]
Breakthroughs in Cardiac Care: 20 Years of Stem Cell Innovation for Heart Health
In a recent event hosted by The Public Lead and moderated by Maya Pomroy, renowned physician-scientists Dr. Deepak Srivastava and Dr. Emerson Perin took the stage to discuss major advancements in stem cell research for cardiac care over the past two decades. This insightful conversation delves into the role of regenerative medicine in treating heart […]
MaxCyte and Kamau Therapeutics Partner to Accelerate Gene Correction with Groundbreaking Stem Cell Therapies for Genetic Diseases
In a groundbreaking move for stem cell therapies, MaxCyte, Inc. has entered into a strategic platform license agreement with Kamau Therapeutics, a clinical-stage company focused on gene correction. The collaboration will leverage MaxCyte’s Flow Electroporation® technology and ExPERT™ platform to expedite the development of innovative therapies targeting genetic diseases. Kamau’s platform, built on homology-directed repair […]
Somite Therapeutics Achieves Key Milestone with FDA Orphan Drug and Rare Pediatric Disease Designations for SMT-M01 in Duchenne Muscular Dystrophy
Somite Therapeutics has announced a major breakthrough in the fight against Duchenne Muscular Dystrophy (DMD), securing both Orphan Drug Designation (ODD) and Rare Pediatric Disease Designation (RPDD) from the FDA for their lead therapeutic candidate, SMT-M01. These designations are critical in the development of therapies targeting rare diseases, offering benefits such as tax credits for […]